We provide the first line of evidence to show that FGFR3 and eIF4E overexpression in CRC may result from PRMT5 overexpression, indicting a new regulatory mechanism for arginine methylation to drive CRC cell proliferation. The gene discussed is FGFR3; the disease is colorectal carcinoma.